We found that EP300-mutated cancers harbored a significantly higher proportion of MSI cancers than EP300-wild-type cancers in COAD and STAD [Fisher’s exact test, p < 0.05, odds ratio (OR) > 4] (Figure 1C). The gene discussed is EP300; the disease is cancer.